Skip to main content
Shannon Blalock, MD, Pediatric Cardiology, Dallas, TX

ShannonElizabethBlalockMD

Pediatric Cardiology Dallas, TX

Medical Director, Pediatric Cardiology East Texas, Children’s Medical Center

Dr. Blalock is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Blalock's full profile

Already have an account?

  • Office

    12201 Merit Dr
    Ste 550
    Dallas, TX 75251
    Phone+1 972-331-9700
    Fax+1 972-331-9833

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Pediatric Cardiology, 2005 - 2008
  • University of Arkansas for Medical Sciences (UAMS) College of Medicine
    University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Pediatrics, 2002 - 2005
  • Texas A&M; Health Science Center College of Medicine
    Texas A&M; Health Science Center College of MedicineClass of 2002

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2005 - 2025
  • American Board of Pediatrics Pediatric Cardiology

Publications & Presentations

PubMed

Press Mentions

  • jCyte Announces Expansion of Role for Chief Commercial Officer Samir Mody
    jCyte Announces Expansion of Role for Chief Commercial Officer Samir ModyOctober 14th, 2021
  • A Pfizer Partner Welcomes Ex-ADC Therapeutics CMO Jay Feingold to the Team; Amid Tough Sledding, Immunovant Chooses Eli Lilly Alum as CFO
    A Pfizer Partner Welcomes Ex-ADC Therapeutics CMO Jay Feingold to the Team; Amid Tough Sledding, Immunovant Chooses Eli Lilly Alum as CFOSeptember 17th, 2021
  • Great Danes: Two Nordic Biotechs Name Their Chief Executives; Axel Hoos Bids Adieu to GlaxoSmithKline, Becomes CEO of Small Oncology Player
    Great Danes: Two Nordic Biotechs Name Their Chief Executives; Axel Hoos Bids Adieu to GlaxoSmithKline, Becomes CEO of Small Oncology PlayerJuly 9th, 2021
  • Join now to see all